We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The lawmakers noted that former FDA Commission Scott Gottlieb had voiced his disapproval for expanding conditional approval pathways to include human medical products. Read More
The agency wants to see risk information on serious eye disorders that can result from unintended exposure to the drug and the potential for severe local skin reactions. Read More